Research Use Only. Products are not for human consumption, clinical use, or veterinary administration. RUO policy

Analytical methods

HPLC and Mass Spectrometry in Peptide Analysis

Plain-language context for two methods frequently referenced on peptide Certificates of Analysis—what each contributes and what neither guarantees alone.

Author: VialVibes research documentation team Reviewer: — (slot reserved) Last reviewed: 2026-07-28

What HPLC measures

High-performance liquid chromatography (HPLC) separates components in a sample as they interact differently with a stationary phase under a defined mobile phase and detection setup. For research peptides, reverse-phase HPLC with UV detection is common.

In the CoA context, HPLC is often used to describe a purity profile: the relative peak areas of species that elute under the method’s conditions. The main peak is typically assigned to the intended peptide (or a closely related species), and other peaks may be reported as related substances or impurities when the method resolves them.

HPLC purity is therefore a method-defined chromatographic result, not a universal chemical “percent of peptide by weight” unless additional orthogonal assays support that interpretation. See also Understanding Peptide Purity Claims.

What mass spectrometry measures

Mass spectrometry (MS) measures mass-to-charge ratios of ions generated from the sample. For peptides, MS supports identity interpretation by comparing observed mass (or charge-state series) with the expected molecular mass of the target sequence or known adducts.

MS alone does not replace chromatographic purity profiling: a mass consistent with the target can coexist with isobaric or co-eluting species depending on method design. Many laboratories report HPLC for profile/purity context and MS for mass confirmation when both are available.

Why both are commonly used

  • Complementary information: HPLC emphasizes separation and relative abundance under detector response; MS emphasizes mass-based identity support.
  • Orthogonal checks: Agreement between a dominant HPLC peak and a mass consistent with the target sequence strengthens confidence relative to either method alone—still within the limits of the methods used.
  • Procurement documentation: Research buyers often request both when institutional quality systems expect dual identity/purity evidence on a lot CoA.

What chromatograms show

A chromatogram plots detector response versus time (or volume). Peaks represent components that elute and produce a detector signal under the chosen conditions. Analysts may annotate:

  • Retention time of the main peak;
  • Relative peak area percentages;
  • Integration windows and system suitability notes when provided;
  • Wavelength or detector type (e.g., UV at a stated nm).

Co-eluting species, baseline noise, and detector response factors affect interpretation. A “clean” looking chromatogram is still method-dependent; different columns, gradients, or detection can change the observed profile.

Limitations

  • HPLC area % is not automatically free-base content, salt-corrected content, or activity in a biological assay.
  • MS confirmation of mass does not prove sequence purity, stereochemistry, or absence of isobaric impurities without further methods.
  • Water, counter-ions, and residual solvents may require separate assays when those data are needed.
  • Results apply to the tested lot and conditions; they do not authorize human or veterinary use of research materials.

Related resources

Scientific reference only — Research Use Only. Educational content for laboratory professionals. VialVibes (operated by APEX Research, LLC) materials are for research use only. RUO policy.